financetom
Business
financetom
/
Business
/
Ciena Insider Sold Shares Worth $1,137,774, According to a Recent SEC Filing
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Ciena Insider Sold Shares Worth $1,137,774, According to a Recent SEC Filing
Jan 7, 2025 12:44 AM

03:20 AM EST, 01/07/2025 (MT Newswires) -- Gary B Smith, Director, President, Chief Executive Officer, on January 02, 2025, sold 13,600 shares in Ciena (CIEN) for $1,137,774. Following the Form 4 filing with the SEC, Smith has control over a total of 425,749 shares of the company, with 425,749 shares held directly.

SEC Filing:

https://www.sec.gov/Archives/edgar/data/936395/000103255325000002/xslF345X05/edgardoc.xml

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Biden administration to limit credit card late fees in move against junk fees
Biden administration to limit credit card late fees in move against junk fees
Mar 5, 2024
March 5 (Reuters) - The Biden administration on Tuesday unveiled its latest measures to combat rising consumer costs and charges known as junk fees, including an interagency effort to crack down on inflated prices and limiting what banks can charge for late credit card payments. The Justice Department and the Federal Trade Commission will lead a joint strike force aimed...
Chubb Unit Prices $1 Billion Senior Notes Offering
Chubb Unit Prices $1 Billion Senior Notes Offering
Mar 5, 2024
05:19 AM EST, 03/05/2024 (MT Newswires) -- Chubb ( CB ) said Tuesday that its Chubb INA Holdings unit has priced a public offering of $1 billion in 5% senior notes due 2034. The notes are guaranteed by the parent company and Chubb ( CB ) said proceeds will be used for general working capital, including the repayment upon maturity...
Novo Nordisk's kidney trial cuts cardiac risk, death by 24%
Novo Nordisk's kidney trial cuts cardiac risk, death by 24%
Mar 5, 2024
COPENHAGEN, March 5 (Reuters) - Novo Nordisk's widely used diabetes drug Ozempic delayed progression of chronic kidney disease in diabetes patients, lowering the risk of major cardiac events and death by 24%, according to a large late-stage study. In October, the Danish drugmaker stopped the trial almost a year ahead of schedule because it was clear from an interim analysis...
Update: NerdWallet Says Bankruptcy Claim Filed in its Name is Fraudulent
Update: NerdWallet Says Bankruptcy Claim Filed in its Name is Fraudulent
Mar 5, 2024
05:17 AM EST, 03/05/2024 (MT Newswires) -- (Updates first and second paragraphs with company's statement.) NerdWallet ( NRDS ) was the victim of a fraudulent bankruptcy claim filed on its behalf in federal court, the company said in an emailed statement to MT Newswires. NerdWallet ( NRDS ) did not file for bankruptcy, a spokesperson for the company said. This...
Copyright 2023-2026 - www.financetom.com All Rights Reserved